메뉴 건너뛰기




Volumn 21, Issue 4, 2012, Pages 389-403

Management of mineral and bone disorder after kidney transplantation

Author keywords

adynamic bone; bisphosphonates; calcineurin inhibitor; fracture; renal osteodystrophy

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIMIMETIC AGENT; CALCINEURIN INHIBITOR; CALCITONIN; CALCITRIOL; CALCIUM; CINACALCET; COLECALCIFEROL; CYCLOSPORIN A; DENOSUMAB; ERGOCALCIFEROL; EVEROLIMUS; FIBROBLAST GROWTH FACTOR 23; IBANDRONIC ACID; MAGNESIUM; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PARICALCITOL; PHOSPHORUS; RAPAMYCIN; RISEDRONIC ACID; STEROID; VITAMIN D; VITAMIN D DERIVATIVE; ZOLEDRONIC ACID;

EID: 84862134995     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283546ee0     Document Type: Review
Times cited : (55)

References (136)
  • 1
    • 81455126813 scopus 로고    scopus 로고
    • United States Renal Data System (USRDS) Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
    • United States Renal Data System (USRDS). USRDS 2011 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2011.
    • (2011) USRDS 2011 Annual Data Report
  • 2
    • 84856464845 scopus 로고    scopus 로고
    • Does the use of mTOR inhibitors increase long-term mortality in kidney recipients?
    • Bunnapradist S, Kalantar-Zadeh K. Does the use of mTOR inhibitors increase long-term mortality in kidney recipients? Am J Transplant 2012; 12:277-278.
    • (2012) Am J Transplant , vol.12 , pp. 277-278
    • Bunnapradist, S.1    Kalantar-Zadeh, K.2
  • 3
    • 42549118601 scopus 로고    scopus 로고
    • Bone and mineral disorders in predialysis CKD
    • Kovesdy CP, Kalantar-Zadeh K. Bone and mineral disorders in predialysis CKD. Int Urol Nephrol 2008; 40:427-440.
    • (2008) Int Urol Nephrol , vol.40 , pp. 427-440
    • Kovesdy, C.P.1    Kalantar-Zadeh, K.2
  • 4
    • 77955167192 scopus 로고    scopus 로고
    • Kidney bone disease and mortality in CKD: Revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals
    • Kalantar-Zadeh K, Shah A, Duong U, et al. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl. 2010; (117):S10-S21.
    • (2010) Kidney Int Suppl , vol.117
    • Kalantar-Zadeh, K.1    Shah, A.2    Duong, U.3
  • 6
    • 0028788558 scopus 로고
    • Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
    • Wang M, Hercz G, Sherrard DJ, et al. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 1995; 26:836-844.
    • (1995) Am J Kidney Dis , vol.26 , pp. 836-844
    • Wang, M.1    Hercz, G.2    Sherrard, D.J.3
  • 10
    • 0029046374 scopus 로고
    • Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation
    • Briner VA, Thiel G, Monier-Faugere MC, et al. Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation. Transplantation 1995; 59:1393-1400.
    • (1995) Transplantation , vol.59 , pp. 1393-1400
    • Briner, V.A.1    Thiel, G.2    Monier-Faugere, M.C.3
  • 12
    • 0022898244 scopus 로고
    • Hypophosphatemia in long-term renal transplant recipients: Effects on bone histology and 1,25-dihydroxycholecalciferol
    • Felsenfeld AJ, Gutman RA, Drezner M, Llach F. Hypophosphatemia in longterm renal transplant recipients: effects on bone histology and 1,25-dihydroxycholecalciferol. Miner Electrolyte Metab 1986; 12:333-341. (Pubitemid 17002640)
    • (1986) Mineral and Electrolyte Metabolism , vol.12 , Issue.5-6 , pp. 333-341
    • Felsenfeld, A.J.1    Gutman, R.A.2    Drezner, M.3    Llach, F.4
  • 14
    • 0025788833 scopus 로고
    • Rapid loss of vertebral mineral density after renal transplantation
    • Julian BA, Laskow DA, Dubovsky J, et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325:544-550.
    • (1991) N Engl J Med , vol.325 , pp. 544-550
    • Julian, B.A.1    Laskow, D.A.2    Dubovsky, J.3
  • 16
    • 0019981068 scopus 로고
    • Hypercalcemic hyperparathyroidism following renal transplantation: Differential diagnosis, management, and implications for cell population control in the parathyroid gland
    • Parfitt AM. Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab 1982; 8:92-112. (Pubitemid 12064108)
    • (1982) Mineral and Electrolyte Metabolism , vol.8 , Issue.2 , pp. 92-112
    • Parfitt, A.M.1
  • 17
    • 0016364912 scopus 로고
    • Hypophosphataemic osteomalacia after cadaveric renal transplantation
    • Moorhead JF, Wills MR, Ahmed KY, et al. Hypophosphataemic osteomalacia after cadaveric renal transplantation. Lancet 1974; 1:694-697.
    • (1974) Lancet , vol.1 , pp. 694-697
    • Moorhead, J.F.1    Wills, M.R.2    Ahmed, K.Y.3
  • 21
    • 37049024719 scopus 로고    scopus 로고
    • Renal osteodystrophy after successful renal transplantation: A histomorphometric analysis in 57 patients
    • DOI 10.1016/j.transproceed.2007.10.001, PII S0041134507012602
    • Lehmann G, Ott U, Stein G, et al. Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients. Transplant Proc 2007; 39:3153-3158. (Pubitemid 350251501)
    • (2007) Transplantation Proceedings , vol.39 , Issue.10 , pp. 3153-3158
    • Lehmann, G.1    Ott, U.2    Stein, G.3    Steiner, T.4    Wolf, G.5
  • 24
    • 0031732356 scopus 로고    scopus 로고
    • Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: A randomized, double blind study in kidney transplant patients
    • Lippuner K, Casez JP, Horber FF, Jaeger P. Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients. J Clin Endocrinol Metab 1998; 83:3795-3802. (Pubitemid 28513553)
    • (1998) Journal of Clinical Endocrinology and Metabolism , vol.83 , Issue.11 , pp. 3795-3802
    • Lippuner, K.1    Casez, J.-P.2    Horber, F.F.3    Jaeger, P.4
  • 25
    • 0346754948 scopus 로고    scopus 로고
    • Bone mineral density changes within six months of renal transplantation
    • DOI 10.1097/00007890-200301150-00009
    • Mikuls TR, Julian BA, Bartolucci A, Saag KG. Bone mineral density changes within six months of renal transplantation. Transplantation 2003; 75:49-54. (Pubitemid 36139694)
    • (2003) Transplantation , vol.75 , Issue.1 , pp. 49-54
    • Mikuls, T.R.1    Julian, B.A.2    Bartolucci, A.3    Saag, K.G.4
  • 26
    • 0033665183 scopus 로고    scopus 로고
    • Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation
    • Nam JH, Moon JI, Chung SS, et al. Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation. Transplant Proc 2000; 32:1876.
    • (2000) Transplant Proc , vol.32 , pp. 1876
    • Nam, J.H.1    Moon, J.I.2    Chung, S.S.3
  • 32
    • 0028879897 scopus 로고
    • Bone loss after kidney transplantation: A longitudinal study in 115 graft recipients
    • Grotz WH, Mundinger FA, Rasenack J, et al. Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 1995; 10:2096-2100.
    • (1995) Nephrol Dial Transplant , vol.10 , pp. 2096-2100
    • Grotz, W.H.1    Mundinger, F.A.2    Rasenack, J.3
  • 35
    • 0033562916 scopus 로고    scopus 로고
    • Increased fracture rate in diabetes mellitus and females after renal transplantation
    • DOI 10.1097/00007890-199905150-00004
    • Nisbeth U, Lindh E, Ljunghall S, et al. Increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation 1999; 67:1218-1222. (Pubitemid 29239471)
    • (1999) Transplantation , vol.67 , Issue.9 , pp. 1218-1222
    • Nisbeth, U.1    Lindh, E.2    Ljunghall, S.3    Backman, U.4    Fellstrom, B.5
  • 36
    • 74949094555 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the care of kidney transplant recipients
    • KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(Suppl. 3):S1-S155.
    • (2009) Am J Transplant , vol.9 , Issue.SUPPL. 3
  • 37
    • 2442449233 scopus 로고    scopus 로고
    • Natural history of parathyroid function and calcium metabolism after kidney transplantation: A single-centre study
    • DOI 10.1093/ndt/gfh128
    • Evenepoel P, Claes K, Kuypers D, et al. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 2004; 19:1281-1287. (Pubitemid 38628152)
    • (2004) Nephrology Dialysis Transplantation , vol.19 , Issue.5 , pp. 1281-1287
    • Evenepoel, P.1    Claes, K.2    Kuypers, D.3    Maes, B.4    Bammens, B.5    Vanrenterghem, Y.6
  • 40
    • 0019505295 scopus 로고
    • Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormone
    • Rosenbaum RW, Hruska KA, Korkor A, et al. Decreased phosphate reabsorption after renal transplantation: evidence for a mechanism independent of calcium and parathyroid hormone. Kidney Int 1981; 19:568-578. (Pubitemid 11120903)
    • (1981) Kidney International , vol.19 , Issue.4 , pp. 568-578
    • Rosenbaum, R.W.1    Hruska, K.A.2    Korkor, A.3
  • 41
    • 0035019829 scopus 로고    scopus 로고
    • Posttransplant hypophosphatemia
    • Levi M. Posttransplant hypophosphatemia. Kidney Int 2001; 59:2377-2387.
    • (2001) Kidney Int , vol.59 , pp. 2377-2387
    • Levi, M.1
  • 42
    • 0035723074 scopus 로고    scopus 로고
    • Evidence for a pth-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia
    • DOI 10.1046/j.1523-1755.2001.0600031182.x
    • Green J, Debby H, Lederer E, et al. Evidence for a PTH-independent humoral mechanism in posttransplant hypophosphatemia and phosphaturia. Kidney Int 2001; 60:1182-1196. (Pubitemid 34205819)
    • (2001) Kidney International , vol.60 , Issue.3 , pp. 1182-1196
    • Green, J.1    Debby, H.2    Lederer, E.3    Levi, M.4    Zajicek, H.K.5    Bick, T.6
  • 43
    • 0029034191 scopus 로고
    • Oncogenic osteomalacia: Evidence for a humoral phosphaturic factor
    • Wilkins GE, Granleese S, Hegele RG, et al. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab 1995; 80:1628-1634.
    • (1995) J Clin Endocrinol Metab , vol.80 , pp. 1628-1634
    • Wilkins, G.E.1    Granleese, S.2    Hegele, R.G.3
  • 44
    • 33749508711 scopus 로고    scopus 로고
    • Posttransplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    • Bhan I, Shah A, Holmes J, et al. Posttransplant hypophosphatemia: tertiary 'Hyper-Phosphatoninism'? Kidney Int 2006; 70:1486-1494.
    • (2006) Kidney Int , vol.70 , pp. 1486-1494
    • Bhan, I.1    Shah, A.2    Holmes, J.3
  • 45
    • 34247382124 scopus 로고    scopus 로고
    • Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients
    • DOI 10.1111/j.1600-6143.2007.01753.x
    • Evenepoel P, Naesens M, Claes K, et al. 'Hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant 2007; 7:1193-1200. (Pubitemid 46643105)
    • (2007) American Journal of Transplantation , vol.7 , Issue.5 , pp. 1193-1200
    • Evenepoel, P.1    Naesens, M.2    Claes, K.3    Kuypers, D.4    Vanrenterghem, Y.5
  • 46
    • 79955456863 scopus 로고    scopus 로고
    • Early posttransplantation hypophosphatemia is associated with elevated FGF-23 levels
    • Trombetti A, Richert L, Hadaya K, et al. Early posttransplantation hypophosphatemia is associated with elevated FGF-23 levels. Eur J Endocrinol 2011; 164:839-847.
    • (2011) Eur J Endocrinol , vol.164 , pp. 839-847
    • Trombetti, A.1    Richert, L.2    Hadaya, K.3
  • 47
    • 58149327147 scopus 로고    scopus 로고
    • Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation
    • Evenepoel P, Meijers BK, de Jonge H, et al. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol 2008; 3:1829-1836.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1829-1836
    • Evenepoel, P.1    Meijers, B.K.2    De Jonge, H.3
  • 48
    • 80655139675 scopus 로고    scopus 로고
    • Association of pretransplant serum phosphorus with posttransplant outcomes
    • Sampaio MS, Molnar MZ, Kovesdy CP, et al. Association of pretransplant serum phosphorus with posttransplant outcomes. Clin J Am Soc Nephrol 2011; 6:2712-2721.
    • (2011) Clin J Am Soc Nephrol , vol.6 , pp. 2712-2721
    • Sampaio, M.S.1    Molnar, M.Z.2    Kovesdy, C.P.3
  • 49
    • 65549116844 scopus 로고    scopus 로고
    • Elevated serum phosphate predicts mortality in renal transplant recipients
    • Connolly GM, Cunningham R, McNamee PT, et al. Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation 2009; 87:1040-1044.
    • (2009) Transplantation , vol.87 , pp. 1040-1044
    • Connolly, G.M.1    Cunningham, R.2    McNamee, P.T.3
  • 50
    • 79954708035 scopus 로고    scopus 로고
    • Association of serum phosphorus level with anemia in kidney transplant recipients
    • Kovesdy CP, Mucsi I, Czira ME, et al. Association of serum phosphorus level with anemia in kidney transplant recipients. Transplantation 2011; 91:875-882.
    • (2011) Transplantation , vol.91 , pp. 875-882
    • Kovesdy, C.P.1    Mucsi, I.2    Czira, M.E.3
  • 51
    • 69149091953 scopus 로고    scopus 로고
    • Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of newonset diabetes after transplantation
    • Van Laecke S, Van Biesen W, Verbeke F, et al. Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of newonset diabetes after transplantation. Am J Transplant 2009; 9:2140-2149.
    • (2009) Am J Transplant , vol.9 , pp. 2140-2149
    • Van Laecke, S.1    Van Biesen, W.2    Verbeke, F.3
  • 56
    • 26044480357 scopus 로고    scopus 로고
    • The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism
    • DOI 10.1093/ndt/gfh924
    • Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20:1311-1314. (Pubitemid 41435024)
    • (2005) Nephrology Dialysis Transplantation , vol.20 , Issue.7 , pp. 1311-1314
    • Kruse, A.E.1    Eisenberger, U.2    Frey, F.J.3    Mohaupt, M.G.4
  • 58
    • 0038102824 scopus 로고    scopus 로고
    • Involution of the parathyroid glands after renal transplantation
    • DOI 10.1097/00041552-200307000-00004
    • Lewin E. Involution of the parathyroid glands after renal transplantation. Curr Opin Nephrol Hypertens 2003; 12:363-371. (Pubitemid 36871859)
    • (2003) Current Opinion in Nephrology and Hypertension , vol.12 , Issue.4 , pp. 363-371
    • Lewin, E.1
  • 59
    • 77954913461 scopus 로고    scopus 로고
    • Calcium, phosphate and parathyroid metabolism in kidney transplanted patients
    • Ambrus C, Molnar MZ, Czira ME, et al. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients. Int Urol Nephrol 2009; 41:1029-1038.
    • (2009) Int Urol Nephrol , vol.41 , pp. 1029-1038
    • Ambrus, C.1    Molnar, M.Z.2    Czira, M.E.3
  • 61
    • 0031779891 scopus 로고    scopus 로고
    • Primary and secondary uraemic hyperparathyroidism: From initial clinical observations to recent findings
    • DOI 10.1093/ndt/13.6.1384
    • Drueke TB. Primary and secondary uraemic hyperparathyroidism: from initial clinical observations to recent findings. Nephrol Dial Transplant 1998; 13:1384-1387. (Pubitemid 28254310)
    • (1998) Nephrology Dialysis Transplantation , vol.13 , Issue.6 , pp. 1384-1387
    • Drueke, T.B.1
  • 62
    • 78049481921 scopus 로고    scopus 로고
    • Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients
    • Krajisnik T, Olauson H, Mirza MA, et al. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int 2010; 78:1024-1032.
    • (2010) Kidney Int , vol.78 , pp. 1024-1032
    • Krajisnik, T.1    Olauson, H.2    Mirza, M.A.3
  • 64
    • 78649802587 scopus 로고    scopus 로고
    • Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate-toadvanced CKD
    • Kovesdy CP, Molnar MZ, Czira ME, et al. Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate-toadvanced CKD. Nephron Clin Pract 2011; 118:c78-c85.
    • (2011) Nephron Clin Pract , vol.118
    • Kovesdy, C.P.1    Molnar, M.Z.2    Czira, M.E.3
  • 65
    • 0030924675 scopus 로고    scopus 로고
    • Serum bone alkaline phosphatase is superior to plasma levels of bone matrix proteins for assessment of bone metabolism in patients receiving renal transplants
    • DOI 10.1016/S0009-8981(97)06519-4, PII S0009898197065194
    • Withold W, Friedrich W, Degenhardt S. Serum bone alkaline phosphatase is superior to plasma levels of bone matrix proteins for assessment of bone metabolism in patients receiving renal transplants. Clin Chim Acta 1997; 261:105-115. (Pubitemid 27214568)
    • (1997) Clinica Chimica Acta , vol.261 , Issue.2 , pp. 105-115
    • Withold, W.1    Friedrich, W.2    Degenhardt, S.3
  • 66
    • 79959968577 scopus 로고    scopus 로고
    • Vitamin D in organ transplantation
    • Stein EM, Shane E. Vitamin D in organ transplantation. Osteoporos Int 2011; 22:2107-2118.
    • (2011) Osteoporos Int , vol.22 , pp. 2107-2118
    • Stein, E.M.1    Shane, E.2
  • 67
    • 79955603792 scopus 로고    scopus 로고
    • Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality
    • Wolf M, Molnar MZ, Amaral AP, et al. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol 2011; 22:956-966.
    • (2011) J Am Soc Nephrol , vol.22 , pp. 956-966
    • Wolf, M.1    Molnar, M.Z.2    Amaral, A.P.3
  • 68
    • 84862143898 scopus 로고    scopus 로고
    • Comparing mortality risk of minerals, PTH and alkaline phosphatase over 6 years in 12 422 chronic peritoneal dialysis (CPD) patients
    • [abstract] NKF Spring Clinical Meetings, 26-30 April 2011; Las Vegas, NV
    • Duong U, Mehrotra R, Kovesdy CP, et al. Comparing mortality risk of minerals, PTH and alkaline phosphatase over 6 years in 12 422 chronic peritoneal dialysis (CPD) patients [abstract]. Am J Kidney Dis 2011; NKF Spring Clinical Meetings, 26-30 April 2011; Las Vegas, NV.
    • (2011) Am J Kidney Dis
    • Duong, U.1    Mehrotra, R.2    Kovesdy, C.P.3
  • 69
    • 0023708625 scopus 로고
    • Cyclosporin-A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration
    • Movsowitz C, Epstein S, Fallon M, et al. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 1988; 123:2571-2577.
    • (1988) Endocrinology , vol.123 , pp. 2571-2577
    • Movsowitz, C.1    Epstein, S.2    Fallon, M.3
  • 70
    • 0030067972 scopus 로고    scopus 로고
    • Post-transplantation bone disease: The role of immunosuppressive agents and the skeleton
    • Epstein S. Posttransplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 1996; 11:1-7. (Pubitemid 26026737)
    • (1996) Journal of Bone and Mineral Research , vol.11 , Issue.1 , pp. 1-7
    • Epstein, S.1
  • 71
    • 0023904536 scopus 로고
    • Bone histology in renal transplant patients receiving cyclosporin
    • Bone histology in renal transplant patients receiving cyclosporin. Lancet 1988; 1:1048-1049.
    • (1988) Lancet , vol.1 , pp. 1048-1049
  • 72
    • 0029049513 scopus 로고
    • Lack of evidence that cyclosporine treatment impairs calcium-phosphorus homeostasis and bone remodeling in normocalcemic long-term renal transplant recipients
    • Dumoulin G, Hory B, Nguyen NU, et al. Lack of evidence that cyclosporine treatment impairs calcium-phosphorus homeostasis and bone remodeling in normocalcemic long-term renal transplant recipients. Transplantation 1995; 59:1690-1694.
    • (1995) Transplantation , vol.59 , pp. 1690-1694
    • Dumoulin, G.1    Hory, B.2    Nguyen, N.U.3
  • 74
    • 0038434107 scopus 로고    scopus 로고
    • Mechanisms of glucocorticoid-induced osteoporosis
    • DOI 10.1097/00002281-200307000-00013
    • Canalis E. Mechanisms of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 2003; 15:454-457. (Pubitemid 36774258)
    • (2003) Current Opinion in Rheumatology , vol.15 , Issue.4 , pp. 454-457
    • Canalis, E.1
  • 75
    • 0025101215 scopus 로고
    • Glucocorticoid-induced osteoporosis: Pathogenesis and management
    • Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112:352-364. (Pubitemid 20083611)
    • (1990) Annals of Internal Medicine , vol.112 , Issue.5 , pp. 352-364
    • Lukert, B.P.1    Raisz, L.G.2
  • 76
    • 33846021310 scopus 로고    scopus 로고
    • Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression
    • DOI 10.1681/ASN.2006050427
    • Cunningham J. Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression. J Am Soc Nephrol 2007; 18:223-234. (Pubitemid 46053435)
    • (2007) Journal of the American Society of Nephrology , vol.18 , Issue.1 , pp. 223-234
    • Cunningham, J.1
  • 77
    • 16244372694 scopus 로고    scopus 로고
    • Posttransplantation bone disease
    • DOI 10.1097/01.TP.0000149698.79739.EF
    • Cunningham J. Posttransplantation bone disease. Transplantation 2005; 79:629-634. (Pubitemid 40463162)
    • (2005) Transplantation , vol.79 , Issue.6 , pp. 629-634
    • Cunningham, J.1
  • 79
    • 33645644577 scopus 로고    scopus 로고
    • Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: A four-year prospective study
    • Marcen R, Caballero C, Pascual J, et al. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study. Transplantation 2006; 81:826-831.
    • (2006) Transplantation , vol.81 , pp. 826-831
    • Marcen, R.1    Caballero, C.2    Pascual, J.3
  • 82
    • 0028914056 scopus 로고
    • Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat
    • Bryer HP, Isserow JA, Armstrong EC, et al. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat. J Bone Miner Res 1995; 10:132-138.
    • (1995) J Bone Miner Res , vol.10 , pp. 132-138
    • Bryer, H.P.1    Isserow, J.A.2    Armstrong, E.C.3
  • 84
    • 38649110155 scopus 로고    scopus 로고
    • Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells
    • DOI 10.1002/jcb.21411
    • Singha UK, Jiang Y, Yu S, et al. Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells. J Cell Biochem 2008; 103:434-446. (Pubitemid 351171915)
    • (2008) Journal of Cellular Biochemistry , vol.103 , Issue.2 , pp. 434-446
    • Singha, U.K.1    Jiang, Y.2    Yu, S.3    Luo, M.4    Lu, Y.5    Zhang, J.6    Xiao, G.7
  • 86
    • 33845635602 scopus 로고    scopus 로고
    • From marrow oedema to osteonecrosis: Common paths in the development of post-transplant bone pain
    • DOI 10.1111/j.1440-1797.2006.00708.x
    • Elder GJ. From marrow oedema to osteonecrosis: common paths in the development of posttransplant bone pain. Nephrology (Carlton) 2006; 11:560-567. (Pubitemid 44951241)
    • (2006) Nephrology , vol.11 , Issue.6 , pp. 560-567
    • Elder, G.J.1
  • 87
    • 79954454601 scopus 로고    scopus 로고
    • Avascular osteonecrosis and accompanying anemia, leucocytosis, and decreased bone mineral density in renal transplant recipients
    • Paydas S, Balal M, Demir E, et al. Avascular osteonecrosis and accompanying anemia, leucocytosis, and decreased bone mineral density in renal transplant recipients. Transplant Proc 2011; 43:863-866.
    • (2011) Transplant Proc , vol.43 , pp. 863-866
    • Paydas, S.1    Balal, M.2    Demir, E.3
  • 88
    • 33749132598 scopus 로고    scopus 로고
    • Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function
    • DOI 10.1097/01.tp.0000230130.50451.78, PII 0000789020060927000006
    • Akaberi S, Lindergard B, Simonsen O, Nyberg G. Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function. Transplantation 2006; 82:749-752. (Pubitemid 44470376)
    • (2006) Transplantation , vol.82 , Issue.6 , pp. 749-752
    • Akaberi, S.1    Lindergard, B.2    Simonsen, O.3    Nyberg, G.4
  • 89
    • 84860291103 scopus 로고    scopus 로고
    • Timing of dialysis initiation in transplant-naive and failed transplant patients
    • Molnar MZ, Ojo AO, Bunnapradist S, et al. Timing of dialysis initiation in transplant-naive and failed transplant patients. Nat Rev Nephrol 2012; 8:284-292.
    • (2012) Nat Rev Nephrol , vol.8 , pp. 284-292
    • Molnar, M.Z.1    Ojo, A.O.2    Bunnapradist, S.3
  • 90
    • 84862125882 scopus 로고    scopus 로고
    • Estimated glomerular filtration rate at re-initiation of dialysis and mortality in failed kidney transplant recipients
    • [Epub ahead of print]
    • Molnar MZ, Streja E, Kovesdy CP, et al. Estimated glomerular filtration rate at re-initiation of dialysis and mortality in failed kidney transplant recipients. Nephrol Dial Transplant 2012. [Epub ahead of print]
    • (2012) Nephrol Dial Transplant
    • Molnar, M.Z.1    Streja, E.2    Kovesdy, C.P.3
  • 91
    • 75749145002 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary
    • Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2010; 77:299-311.
    • (2010) Kidney Int , vol.77 , pp. 299-311
    • Kasiske, B.L.1    Zeier, M.G.2    Chapman, J.R.3
  • 94
    • 0034722682 scopus 로고    scopus 로고
    • Prevention of bone loss with alendronate in kidney transplant recipients
    • Kovac D, Lindic J, Kandus A, Bren AF. Prevention of bone loss with alendronate in kidney transplant recipients. Transplantation 2000; 70:1542-1543.
    • (2000) Transplantation , vol.70 , pp. 1542-1543
    • Kovac, D.1    Lindic, J.2    Kandus, A.3    Bren, A.F.4
  • 96
    • 0345446519 scopus 로고    scopus 로고
    • Prevalence and treatment of decreased bone density in renal transplant recipients: A randomized prospective trial of calcitriol versus alendronate
    • Jeffery JR, Leslie WD, Karpinski ME, et al. Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate. Transplantation 2003; 76:1498-1502.
    • (2003) Transplantation , vol.76 , pp. 1498-1502
    • Jeffery, J.R.1    Leslie, W.D.2    Karpinski, M.E.3
  • 98
    • 0347992781 scopus 로고    scopus 로고
    • Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation
    • DOI 10.1111/j.1523-1755.2004.00369.x
    • Schwarz C, Mitterbauer C, Heinze G, et al. Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation. Kidney Int 2004; 65:304-309. (Pubitemid 38037518)
    • (2004) Kidney International , vol.65 , Issue.1 , pp. 304-309
    • Schwarz, C.1    Mitterbauer, C.2    Heinze, G.3    Woloszczuk, W.4    Haas, M.5    Oberbauer, R.6
  • 99
    • 0038527220 scopus 로고    scopus 로고
    • Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation
    • DOI 10.1046/j.1523-1755.2003.00012.x
    • Fan SL, Kumar S, Cunningham J. Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation. Kidney Int 2003; 63:2275-2279. (Pubitemid 36605842)
    • (2003) Kidney International , vol.63 , Issue.6 , pp. 2275-2279
    • Fan, S.L.-S.1    Kumar, S.2    Cunningham, J.3
  • 101
    • 64749099481 scopus 로고    scopus 로고
    • Effect of pamidronate on bone loss after kidney transplantation: A randomized trial
    • Walsh SB, Altmann P, Pattison J, et al. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial. Am J Kidney Dis 2009; 53:856-865.
    • (2009) Am J Kidney Dis , vol.53 , pp. 856-865
    • Walsh, S.B.1    Altmann, P.2    Pattison, J.3
  • 102
    • 78651517470 scopus 로고    scopus 로고
    • Efficacy of low doses of pamidronate in osteopenic patients administered in the early postrenal transplant
    • Torregrosa JV, Fuster D, Monegal A, et al. Efficacy of low doses of pamidronate in osteopenic patients administered in the early postrenal transplant. Osteoporos Int 2011; 22:281-287.
    • (2011) Osteoporos Int , vol.22 , pp. 281-287
    • Torregrosa, J.V.1    Fuster, D.2    Monegal, A.3
  • 104
    • 77954083368 scopus 로고    scopus 로고
    • Open-label trial: Effect of weekly risedronate immediately after transplantation in kidney recipients
    • Torregrosa JV, Fuster D, Gentil MA, et al. Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients. Transplantation 2010; 89:1476-1481.
    • (2010) Transplantation , vol.89 , pp. 1476-1481
    • Torregrosa, J.V.1    Fuster, D.2    Gentil, M.A.3
  • 105
    • 33644517247 scopus 로고    scopus 로고
    • Bisphosphonates are effective prophylactic of early bone loss after renal transplantation
    • Nowacka-Cieciura E, Cieciura T, Baczkowska T, et al. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation. Transplant Proc 2006; 38:165-167.
    • (2006) Transplant Proc , vol.38 , pp. 165-167
    • Nowacka-Cieciura, E.1    Cieciura, T.2    Baczkowska, T.3
  • 111
    • 77958596053 scopus 로고    scopus 로고
    • Effect of paricalcitol on the urinary peptidome of kidney transplant patients
    • Perez V, Sanchez A, Bayes B, et al. Effect of paricalcitol on the urinary peptidome of kidney transplant patients. Transplant Proc 2010; 42:2924-2927.
    • (2010) Transplant Proc , vol.42 , pp. 2924-2927
    • Perez, V.1    Sanchez, A.2    Bayes, B.3
  • 112
    • 26044459454 scopus 로고    scopus 로고
    • Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism
    • DOI 10.1093/ndt/gfh925
    • Serra AL, Schwarz AA, Wick FH, et al. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dialy Transplant 2005; 20:1315-1319. (Pubitemid 41430604)
    • (2005) Nephrology Dialysis Transplantation , vol.20 , Issue.7 , pp. 1315-1319
    • Serra, A.L.1    Schwarz, A.A.2    Wick, F.H.3    Marti, H.-P.4    Wuthrich, R.P.5
  • 113
    • 33748680484 scopus 로고    scopus 로고
    • Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism
    • DOI 10.1097/01.tp.0000232452.80018.ad, PII 0000789020060915000013
    • Szwarc I, Argiles A, Garrigue V, et al. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 2006; 82:675-680. (Pubitemid 44395239)
    • (2006) Transplantation , vol.82 , Issue.5 , pp. 675-680
    • Szwarc, I.1    Argiles, A.2    Garrigue, V.3    Delmas, S.4    Chong, G.5    Deleuze, S.6    Mourad, G.7
  • 114
    • 33745607742 scopus 로고    scopus 로고
    • Improvement in hypercalcemia with cinacalcet after kidney transplantation
    • Srinivas TR, Schold JD, Womer KL, et al. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol 2006; 1:323-326.
    • (2006) Clin J Am Soc Nephrol , vol.1 , pp. 323-326
    • Srinivas, T.R.1    Schold, J.D.2    Womer, K.L.3
  • 115
    • 34548677964 scopus 로고    scopus 로고
    • Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism
    • DOI 10.1016/j.transproceed.2007.07.079, PII S0041134507009190
    • Bergua C, Torregrosa JV, Cofan F, Oppenheimer F. Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism. Transplant Proc 2007; 39:2254-2255. (Pubitemid 47418225)
    • (2007) Transplantation Proceedings , vol.39 , Issue.7 , pp. 2254-2255
    • Bergua, C.1    Torregrosa, J.-V.2    Cofan, F.3    Oppenheimer, F.4
  • 116
    • 52049090659 scopus 로고    scopus 로고
    • Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism
    • Bergua C, Torregrosa JV, Fuster D, et al. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Transplantation 2008; 86:413-417.
    • (2008) Transplantation , vol.86 , pp. 413-417
    • Bergua, C.1    Torregrosa, J.V.2    Fuster, D.3
  • 117
    • 68949216330 scopus 로고    scopus 로고
    • Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism
    • Lopez V, Toledo R, Sola E, et al. Treatment with cinacalcet in 29 kidney transplant patients with persistent hyperparathyroidism. Transplant Proc 2009; 41:2394-2395.
    • (2009) Transplant Proc , vol.41 , pp. 2394-2395
    • Lopez, V.1    Toledo, R.2    Sola, E.3
  • 118
    • 77951534081 scopus 로고    scopus 로고
    • Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation
    • Borchhardt KA, Diarra D, Sulzbacher I, et al. Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation. Am J Nephrol 2010; 31:482-489.
    • (2010) Am J Nephrol , vol.31 , pp. 482-489
    • Borchhardt, K.A.1    Diarra, D.2    Sulzbacher, I.3
  • 119
    • 78649472772 scopus 로고    scopus 로고
    • Cinacalcet improves bone density in postkidney transplant hyperparathyroidism
    • Cho ME, Duan Z, Chamberlain CE, et al. Cinacalcet improves bone density in postkidney transplant hyperparathyroidism. Transplant Proc 2010; 42:3554-3558.
    • (2010) Transplant Proc , vol.42 , pp. 3554-3558
    • Cho, M.E.1    Duan, Z.2    Chamberlain, C.E.3
  • 120
    • 77956495287 scopus 로고    scopus 로고
    • Evaluation of cinacalcet HCl treatment after kidney transplantation
    • Copley JB, Germain M, Stern L, et al. Evaluation of cinacalcet HCl treatment after kidney transplantation. Transplant Proc 2010; 42:2503-2508.
    • (2010) Transplant Proc , vol.42 , pp. 2503-2508
    • Copley, J.B.1    Germain, M.2    Stern, L.3
  • 121
    • 79952190801 scopus 로고    scopus 로고
    • The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism
    • Schwarz A, Merkel S, Leitolf H, Haller H. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism. Transplantation 2011; 91:560-565.
    • (2011) Transplantation , vol.91 , pp. 560-565
    • Schwarz, A.1    Merkel, S.2    Leitolf, H.3    Haller, H.4
  • 122
    • 79951941014 scopus 로고    scopus 로고
    • Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation
    • Pinho LR, Ribeiro Santos MJ, Pestana Vasconcelos M. Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation. Clin Nephrol 2011; 75:263-268.
    • (2011) Clin Nephrol , vol.75 , pp. 263-268
    • Pinho, L.R.1    Ribeiro Santos, M.J.2    Pestana Vasconcelos, M.3
  • 123
    • 84857640853 scopus 로고    scopus 로고
    • Reduced fracture risk with early corticosteroid withdrawal after kidney transplant
    • Nikkel LE, Mohan S, Zhang A, et al. Reduced fracture risk with early corticosteroid withdrawal after kidney transplant. Am J Transplant 2012; 12:649-659.
    • (2012) Am J Transplant , vol.12 , pp. 649-659
    • Nikkel, L.E.1    Mohan, S.2    Zhang, A.3
  • 124
    • 0038460320 scopus 로고    scopus 로고
    • The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients
    • DOI 10.1111/j.1432-2277.2003.tb00268.x
    • Van den Ham EC, Kooman JP, Christiaans ML, van Hooff JP. The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients. Transpl Int 2003; 16:82-87. (Pubitemid 36682203)
    • (2003) Transplant International , vol.16 , Issue.2 , pp. 82-87
    • Van Den Ham, E.C.H.1    Kooman, J.P.2    Christiaans, M.H.L.3    Van Hooff, J.P.4
  • 125
    • 0033774719 scopus 로고    scopus 로고
    • A meta-analysis of immunosuppression withdrawal trials in renal transplantation
    • Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11:1910-1917.
    • (2000) J Am Soc Nephrol , vol.11 , pp. 1910-1917
    • Kasiske, B.L.1    Chakkera, H.A.2    Louis, T.A.3    Ma, J.Z.4
  • 126
    • 9244234438 scopus 로고    scopus 로고
    • Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: A meta-analysis of randomized, controlled trials
    • DOI 10.1097/01.TP.0000140969.43761.1F
    • Pascual J, Quereda C, Zamora J, Hernandez D. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation 2004; 78:1548-1556. (Pubitemid 39552943)
    • (2004) Transplantation , vol.78 , Issue.10 , pp. 1548-1556
    • Pascual, J.1    Quereda, C.2    Zamora, J.3    Hernandez, D.4
  • 127
    • 80655145200 scopus 로고    scopus 로고
    • Prevention of fractures after solid organ transplantation: A meta-analysis
    • Stein EM, Ortiz D, Jin Z, et al. Prevention of fractures after solid organ transplantation: a meta-analysis. J Clin Endocrinol Metab 2011; 96:3457-3465.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 3457-3465
    • Stein, E.M.1    Ortiz, D.2    Jin, Z.3
  • 128
    • 0029811270 scopus 로고    scopus 로고
    • Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients
    • Talalaj M, Gradowska L, Marcinowska-Suchowierska E, et al. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients. Transplant Proc 1996; 28:3485-3487. (Pubitemid 26415565)
    • (1996) Transplantation Proceedings , vol.28 , Issue.6 , pp. 3485-3487
    • Talalaj, M.1    Gradowska, L.2    Marcinowska-Suchowierska, E.3    Durlik, M.4    Gaciong, Z.5    Lao, M.6
  • 129
    • 84862120022 scopus 로고    scopus 로고
    • Association of dietary phosphorus to protein ratio with mortality in hemodialysis patients
    • [abstract] NKF Spring Clinical Meeting 13-17 April 2010, Lake Buena Vista, FL
    • Noori N, Kalantar-Zadeh K, Kovesdy CP, et al. Association of dietary phosphorus to protein ratio with mortality in hemodialysis patients [abstract]. Am J Kidney Dis 2010; NKF Spring Clinical Meeting, 13-17 April 2010, Lake Buena Vista, FL.
    • (2010) Am J Kidney Dis
    • Noori, N.1    Kalantar-Zadeh, K.2    Kovesdy, C.P.3
  • 130
    • 80054754774 scopus 로고    scopus 로고
    • Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism
    • Zitt E, Woess E, Mayer G, Lhotta K. Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism. Transplantation 2011; 92:883-889.
    • (2011) Transplantation , vol.92 , pp. 883-889
    • Zitt, E.1    Woess, E.2    Mayer, G.3    Lhotta, K.4
  • 131
    • 49649090635 scopus 로고    scopus 로고
    • Effect of teriparatide on early bone loss after kidney transplantation
    • Cejka D, Benesch T, Krestan C, et al. Effect of teriparatide on early bone loss after kidney transplantation. Am J Transplant 2008; 8:1864-1870.
    • (2008) Am J Transplant , vol.8 , pp. 1864-1870
    • Cejka, D.1    Benesch, T.2    Krestan, C.3
  • 132
    • 79961022739 scopus 로고    scopus 로고
    • Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyroidectomized patients: A series of five case reports
    • Nogueira EL, Costa AC, Santana A, et al. Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyroidectomized patients: a series of five case reports. Transplantation 2011; 92:316-320.
    • (2011) Transplantation , vol.92 , pp. 316-320
    • Nogueira, E.L.1    Costa, A.C.2    Santana, A.3
  • 135
    • 0041966210 scopus 로고    scopus 로고
    • Resistance training prevents vertebral osteoporosis in lung transplant recipients
    • DOI 10.1097/01.TP.0000076471.25132.52
    • Mitchell MJ, Baz MA, Fulton MN, et al. Resistance training prevents vertebral osteoporosis in lung transplant recipients. Transplantation 2003; 76:557-562. (Pubitemid 37013263)
    • (2003) Transplantation , vol.76 , Issue.3 , pp. 557-562
    • Mitchell, M.J.1    Baz, M.A.2    Fulton, M.N.3    Lisor, C.F.4    Braith, R.W.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.